Cuthbertson DP: Observations on disturbance of metabolism produced by injury to the limbs. J Med25:233-246, 1932
2.
Shaw JHF , Wildlore M., Wolfe RR: Whole body protein kinetics in severely septic patients. Ann Surg205:288-296, 1987
3.
Shaw JHF , Wolfe RRAn integrated analysis of glucose, fat and protein metabolism in severely traumatized patients. Ann Surg209:63-72, 1989
4.
Shaw JHF , Wolfe RRWhole body protein kinetics in patients with either early or advanced gastroinestinal cancer. Surgery103:148-155, 1988
5.
Shaw JHF , Humberstone DA, Wolfe RREnergy and protein metabolism in sarcoma patients. Ann Surg207:283-289, 1988
6.
Jeevanandam M., Lowry SF, Brennan MFEffect of the route of nutrient administration on whole-body protein kinetics in man. Metabolism36:968-973, 1987
7.
Douglas, RG, Shaw JHF: The effect of lipid infusion, glucose infusion, growht hormone injection and/or TPN on whole body protein kinetics and tissue metabolism in cancer patients . In preparation
8.
Jeevanandam M., Horowitz GD, Lowry SF, Legaspi A., Brennan MFCancer cachexia: Effect of total parenteral nutrition on whole body protein kinetics in man . JPEN9:108, 1985
9.
Shenkin A., Neuhauser M., Bergstrom J., et al: Biochemical changes associated with severe trauma. Am J Clin Nutr33:2119-2127, 1980
10.
Clague MB, Keir MJH, Weight PD, Johnston IDA.The effects of nutrition and trauma on whole-body protein metabolism in man . Clin Sci65:165-175, 1983
11.
Shaw JHF , Gader LMThe effect of extradural blockade on glucose and urea kinetics in surgical patients. Surg Gynecol Obstet165:260-266, 1987
12.
Shaw JHF , Wolfe RR: Metabolic intervention in surgical patients . Ann Surg207:283-289, 1988
13.
Shaw JHF , Holdanoy CM, Humberstone DAThe effect of alpha or beta adrenergic blockade on glucose and protein metabolism in surgical patients receiving TPN. Surgery103:520-525, 1988
14.
Tischler ME , Rosenberg S., Satarug S., et al: Different mechanisms of increased proteolysis in atrophy induced by denervation or unweighting of rat soleus muscle. Metabolism39:756-763, 1990
15.
Albert JD, Matthews DE, Legaspi A., et al: Exercise-mediated peripheral tissue and whole-body amino acid metabolism during intravenous feeding in normal man. Clin Sci77:113-120, 1989
16.
Fong Y., Hesse DG, Tracey KJ, et al: Submaximal exercise during intravenous hyperalimentation of depleted subjects. Ann Surg207:297-304, 1988
17.
Gelfand RA, Matthews DE, Bier DM, Sherwin RS: Role of counterregulatory hormones in the catabolic response to stress . J Clin Invest74:2238-2248, 1984
18.
Bessey PQ, Walters JM, Aoke TT, et al: Combined hormonal infusion stimulates the metabolic response to injury. Ann Surg200:264-281, 1984
19.
Matthews DE , Pesola G., Campbell RG: Effect of epinephrine on amino acids and energy metabolism in humans. Am J Physiol258:E948-E956, 1990
20.
Clutter WE, Bier DM, Shah SD, Cryer PE: Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. J Clin Invest66:94-101, 1980
21.
Galster AD, Clutter WE, Cryer PE, et al: Epinephrine plasma thresholds for lipolytic effects in man: Measurement of fatty acid transport with [1-13C]-palmitic acid. J Clin Invest67:1729-1738, 1981
22.
Sjöstrom L., Schutz Y., Gudinchet F., et al: Epinephrine sensitivity and respect to metabolic rate and other variables in women. Am J Physiol245(Endocrinol. Metab. 8):E431-E422, 1983
23.
Staten MA, Matthews DE, Cryer PE, Bier DM: Physiological increments in epinephrine stimulate metabolic rate in humans . Am J Physiol253( Endocrinol. Metab. 16):E322-E330, 1987
24.
Ingle DJ, Ward EO, Kuizenga MHThe relationship of the adrenal glands to changes in urinary non-protein nitrogen following multiple fractures in the force-fed rat. Am J Physiol149:510-515, 1947
25.
Frayn KN: Hormonal control of metabolism in trauma and sepsis. Clin Endocrin24:577-599, 1986
26.
Nair KS, Halliday D., Matthews DE, Welle SL: Hyperglucagonemia during insulin deficiency accelerates protein catabolism . Am J Physiol253:E208-E218, 1987
27.
Couet C., Fukagawa NK, Matthews DE, et al: Plasma amino acid kinetics during acute states of glucagon deficiency and excess in healthy adults. Am J Physiol258:E78-E85, 1990
28.
Barrett EJ, Revkin JH, Young LH, et al: An isotopic method for measurement of muscle protein synthesis and degradation in vivo. Biochem J245:223-228, 1987
29.
Gelfand RA, Barrett EJEffect of physiological hyperinsulinemia on skeletal muscle protein synthesis and breakdown in man. J Clin Invest80:1-6, 1987
30.
Fukagawa NK , Minaker KL, Rowe JW, et al: Insulin-mediated reduction of whole body protein breakdown: Dose-response effects of leucine metabolism in postabsorptive men. J Clin Invest76:2306-2311, 1985
31.
Tessari P., Trevisan R., Inchiostro S., et al: Dose-response curves of effects of insulin on leucine kinetics in humans. Am J Physiol251:E334-E342, 1986
32.
Flakoll PJ, Kulaylat M., Frexes-Steed M., et al: Amino acids augment insulin's suppression of whole body proteolysis . Am J Physiol2570:E839-E847, 1989
33.
Moss DK, Tischler ME, Fagan J.: Response to trauma of protein, amino acid and carbohydrate metabolism in injured and uninjured rat skeletal muscle. Metabolism32:853-868, 1983
34.
Hurst M., Tischler ME, Cammisa H.Metabolism of protein, amino acid and glucose and their response to insulin in atria and cardiac myocytes of traumatized rats. Metabolism33:515-520, 1984
35.
Tischler ME, Leng E., Al-Kanhal M., et al: Metabolic response of muscle to trauma: Altered control of protein turnover. IN Clinical Nutrition and Metabolic Research. Deitzl G, Grunert A, Kleinberger G, Wolfram G (eds). Karger-Basel, 1986; pp 40-53
36.
Brown LL, Williams PE, Becker TA, et al: Rapid high-performance liquid chromatographic method to measure plasma leucine: importance in the study of leucine kinetics in vivo. J Chromatograph426:370-375, 1988
37.
Frexes-Steed M., Warner ML, Bulus N., et al: Role of insulin and branched-chain amino acids in regulating protein metabolism during fasting . Am J Physiol258:E907-E917, 1990
38.
Deleted in press.
39.
Carraro F., Rosenblatt J., Wolfe RR: Isotopic determination of fibronectin synthesis in humans. Metabolism, in press
40.
Jahor F., Shangraw RE, Miyoshi H., et al: Role of insulin and glucose oxidation in mediating the post-catabolic response in burns and sepsis. Am J Physiol257:E323-332, 1989
41.
Van Wyk JJ , Casella SJ, Hynes M., Lund PKIndirect actions of growth hormone. IN Human Growth Hormone, Underwood LE (ed). Marcel Dekker, New York, NY. 1988, pp. 25-61
42.
Isaksson OGP , Eden S., Jansson J-O.: Mode of action of pituitary growth hormone on target cells. Ann Rev Physiol47:483-499, 1985
43.
Green H., Morikawa M., Nixon T.: A dual effector theory of growth-hormone action. Differentiation29:195-198, 1985
44.
D'Ercole AJ , Stiles AD, Underwood LE: Tissue concentrations of somatomedin-C. Further evidence of multiple sites of synthesis and paracrine or autocrine mechanisms of actions. Proc Natl Acad Sci USA81:935-(39, 1984
45.
Manson JM, Wilmore DWPositive nitrogen balance with human growth hormone and hypocaloric intravenous feeding. Surgery100:188-1987, 1986
46.
Ziegler TR, Young LS, Manson JM, Wilmore DW: Metabolic effects of recombinant human growth hormone in patients receiving parenteral nutrition. Ann Surg208:6-15, 1988
47.
Fong Y., Rosenbaum M., Tracey KJ, et al: Recombinant growth hormone enhances muscle myosin heavy-chain mRNA accumulation and amino acid accrual in humans. Proc Natl Acad Sci86:3371-33-,4,1989
48.
Ward HCHalliday D., Sim AJW: Protein and energy metabolism with biosynthetic human growth hormone after gastrointestinal surgery. Ann Surg206:56-61, 1987
49.
Fong Y., Rosenbaum M., Hesse DG, et al: Influence of substrate background on peripheral tissue responses to growth hormone. J Surg Res44:702-708. 1988
50.
Horber FF, Haymond MW: Human growth hormone prevents the protein catabolic side effects of prednisone in humans. J Clin Invest86:265-272. 1990
51.
Unterman TG , Phillips LS: Glucocorticoid effects on somatomedins and somatomedin inhibitors. J Clin Endocrinol Metab61:618-626, 1985
52.
Clemmons DR , Underwood LE, Dickerson RN, et al: Use of plasma somatomedin-C/insulin like growth factor I measurements to monitor the response to nutritional repletion in malnourished patients. Am J Clin Nutr41:191-198, 1985
53.
Phillips LS , Unterman TG: Somatomedin activity in disorders of nutrition and metabolism. Clin Endocrinol Metab13:145-189, 1984
54.
Isley WL, Underwood LE, Clemmons DRDietary components that regulate serum somatomedin-C concentrations in humans . J Clin Invest71:175-182, 1983
55.
Clemmons DR , Van Wyk JJFactors influencing blood concentrations of somatomedins. J Clin Endocrinol Metab63:113-143, 1984
56.
Underwood LE , Clemmons DR, Maes M., et al: Regulation of somatomedin-C/insulin-like growth factor I by nutrients. Hormone Res24:166-176, 1986
57.
Deleted in press.
58.
Fong Y., Moldawer LL, Shires GTLowry SFThe biological characteristics of cytokines and their implication in surgical injury. Surg Gynecol Obstet170:363-378, 1990
59.
Tracey KJ, Lowry SF: The role of cytokines in septic shock. IN Advances in Surgery , Tompkins RK (ed). Yearbook Medical Publishers, Chicago IL , 1989, pp 21-56
60.
Moldawer LL , Lowry SFCerami A.Cachectin: Its impact on metabolism and nutritional status. Ann Rev Nutr8:585-609, 1988
61.
Kriegler M. , Perez C., DeFay K., et al: A novel form of TNF/ cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell53:45-53, 1988
62.
Keogh CV, Fong Y., Barber A., et al: Identification of a novel cell-associated murine tumor necrosis factor. Arch Surg125:79-85, 1990
63.
Starnes HF, Warren RS, Jeevanandam M., et al: Tumor necrosis factor and the acute metabolic response to tissue injury in man. J Clin Invest82:1321-1325, 1988
64.
Baracos V., Rodemann HP, Dinarello CA, Goldberg AL: Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (Interleukin-1). N Engl J Med308:553-558, 1983
65.
Sobrado J., Moldawer LL, Bistrian BR, et al: Effect of ibuprofen on fever and metabolic changes induced by a continuous infusion of leukocytic pyrogen (Interleukin 1) or endotoxin. Infect Immun42:997-1005, 1983
66.
Clowes GHA Jr, George BC, Villee CA, Sarvis CA: Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma. N Engl J Med308:545-552, 1983
67.
Moldawer LL , Svaninger G., Gelin J., Lundholm K.: Interleukin 1 (alpha or beta) and tumour necrosis factor-alpha do not regulate protein balance in skeletal muscle. Am J Physiol253:C766-C773, 1987
68.
Fong Y., Moldawer LL, Marano M., et al: Cachectin/TNF or IL-1α induces cachexia with redistribution of body proteins. Am J Physiol256:R659-R665, 1989
69.
Fong Y., Marano MA, Moldawer LL, et al: The acute splanchnic and peripheral tissue metabolic response to endotoxin in man. J Clin Invest85:1896-1904, 1990
70.
Walters JM, Bessey PQ, Dinarello CA et al: The induction of interleukin-1 in humans and its metabolic effects . Surgery98:298-308, 1985
71.
Waage A., Halstensen A., Shalaby R., et al: Local production of tumor necrosis factor a. Interleukin 1. and Interleukin 6 in meningococcal meningitis. Relation to the inflammatory response. J Exp Med170:1859-1867, 1989
72.
Tracey KJ, Lowry SF, Fahey TJ, et al: Cachectin/tumor necrosis factor induces lethal septic shock and stress hormone responses in the dog. Surg Gynecol Obstet164:415-422, 1987
73.
Warren RS, Starnes HF, Gabrilove JI et al: The acute metabolic effects of tumor necrosis factor administration in humans. Arch Surg122:1396-1400, 1987
74.
Fong Y., Tracy KJ, Moldawer LL, et al: Antibodies to cachectin/ TNF reduce Interleukin-1β and Interleukin-6 appearance during lethal bacteremia. J Exp Med170:1627-1633, 1989
75.
Flores EA, Bistrian BR, Pomposelli JJ, et al: Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. J Clin Invest83:1614-1622, 1989
76.
Marano MA, Fong Y., Moldawer LL, et al: Serum cachectin/TNF in critically ill burn patients correlates with infection and mortality. Surg Gynecol Obstet170:32-38, 1990
77.
Fong Y., Marano MA, Barber A., et al: Total parenteral nutrition and bowel rest modify the metabolic response to endotoxin in man. Ann Surg210:449-457, 1989
78.
Barber AE, Jones WG, Minei JP, et al: Glutamine or fiber supplementation of a defined formula diet: Impact on bacterial translocation, tissue composition, and response to endotoxin . JPEN14:335-343, 1990
79.
Helfgott DC , Tatter SB, Santhanam U., et al. Multiple forms of IFN-β2/IL-6 in serum and body fluids during acute bacterial infection . J Immunol142:948-953, 1989
80.
Guo Y., Dickerson C., Chrest FJ, et al: Increased levels of circulating interleukin 6 in burn patients . Clin Immunol Immunopathol54:361-371, 1990
81.
Gelin J., Moldawer LL, Englesse I., et al: Appearance of hybridoma growth factor/Interleukin-6 in the serum of mice bearing a methylcholanthrene-induced sarcoma. Biochem Biophys Res Commun157:575-579, 1988
82.
Fong Y., Moldawer LL, Marano M., et al: Endotoxemia elicits increased circulating B2-Interferon/Interleukin-6 in man. J Immunol142 :2321-2325, 1989
83.
Tracey KJ, Fong Y., Hesse DG, et al: Anticachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature330:662-664, 1987
84.
Breder CD, Dinarello CA, Saper CBInterleukin-1 immunoreactive innervation of the human hypothalamus . Science240:321-324, 1988
